Search Results - "TRABOULSEE, A"
-
1
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
Published in American journal of neuroradiology : AJNR (01-03-2016)“…An international group of neurologists and radiologists developed revised guidelines for standardized brain and spinal cord MR imaging for the diagnosis and…”
Get full text
Journal Article -
2
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Published in The New England journal of medicine (19-01-2017)“…In two trials involving patients with relapsing multiple sclerosis, the anti-CD20+ monoclonal antibody ocrelizumab was associated with lower annualized relapse…”
Get full text
Journal Article -
3
-
4
What Have We Learned from Perfusion MRI in Multiple Sclerosis?
Published in American journal of neuroradiology : AJNR (01-06-2018)“…Using MR imaging, perfusion can be assessed either by dynamic susceptibility contrast MR imaging or arterial spin-labeling. Alterations of cerebral perfusion…”
Get full text
Journal Article -
5
Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology
Published in Multiple sclerosis (01-12-2006)“…Various magnetic resonance (MR) techniques are used to study the pathological evolution of demyelinating diseases, such as multiple sclerosis (MS). However,…”
Get full text
Journal Article -
6
FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion Detection
Published in American journal of neuroradiology : AJNR (01-02-2016)“…FLAIR and double inversion recovery are important MR imaging scans for MS. The suppression of signal from CSF in FLAIR and the additional suppression of WM…”
Get full text
Journal Article -
7
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Published in Neurology (18-10-2011)“…To evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis (SPMS) who express human leukocyte antigen (HLA)…”
Get full text
Journal Article -
8
Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis
Published in Behavioural brain research (15-01-2016)“…•Corticospinal excitability and inhibition are altered in individuals with MS.•Cortical and interhemispheric excitability accounts for unique variance in…”
Get full text
Journal Article -
9
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial
Published in Journal of neurology, neurosurgery and psychiatry (01-08-2010)“…BackgroundEvidence for efficacy of disease-modifying drugs in multiple sclerosis (MS) comes from trials of short duration. We report results from a 16 y,…”
Get full text
Journal Article -
10
Acute disseminated encephalomyelitis following influenza vaccination
Published in Vaccine (26-10-2011)“…Highlights ► We present a case of post-vaccination acute disseminated encephalomyelitis (ADEM) following seasonal influenza vaccination. ► We perform a…”
Get full text
Journal Article -
11
Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents
Published in American journal of neuroradiology : AJNR (01-09-2018)“…Dose-dependent association between hyperintensity in deep brain structures on unenhanced T1WIs and gadolinium-based contrast agent administrations has been…”
Get full text
Journal Article -
12
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
Published in Multiple sclerosis (01-01-2016)“…Background: Few biomarkers of progressive multiple sclerosis (MS) are sensitive to change within the two-year time frame of a clinical trial. Objective: To…”
Get full text
Journal Article -
13
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
Published in Neurology (26-09-2006)“…To conduct systematic long-term follow-up (LTFU) of patients in the Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple…”
Get full text
Journal Article -
14
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes
Published in Multiple sclerosis (01-04-2014)“…Background: The 2005 and 2010 McDonald criteria utilize magnetic resonance imaging (MRI) to provide evidence of disease dissemination in space (DIS) and time…”
Get full text
Journal Article -
15
Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis
Published in Multiple sclerosis (01-06-2010)“…Background: Spinal cord involvement in multiple sclerosis (MS) is common and an important element in disability. Previous studies demonstrated smaller cervical…”
Get full text
Journal Article -
16
Standardized MR imaging protocol for multiple sclerosis : Consortium of MS centers consensus guidelines
Published in AJNR. American journal of neuroradiology (01-02-2006)Get full text
Journal Article Conference Proceeding -
17
Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS
Published in Neurology (08-06-2010)Get full text
Journal Article -
18
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS
Published in Neurology (08-06-2010)“…The 16-Year Long-Term Follow-Up (LTF) to the pivotal interferon-beta-1b (IFNbeta-1b) trial explored clinical, MRI, cognitive, and patient-reported outcomes…”
Get full text
Journal Article -
19
FLAIR2 improves LesionTOADS automatic segmentation of multiple sclerosis lesions in non-homogenized, multi-center, 2D clinical magnetic resonance images
Published in NeuroImage clinical (01-01-2019)“…BACKGROUNDAccurate segmentation of MS lesions on MRI is difficult and, if performed manually, time consuming. Automatic segmentations rely strongly on the…”
Get full text
Journal Article -
20
Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
Published in Multiple sclerosis (01-10-2009)“…Minocycline is proposed as an add-on therapy to improve the efficacy of glatiramer acetate in relapsing—remitting multiple sclerosis. The effect of minocycline…”
Get full text
Journal Article